Trial intelligence / Profile preview

EDHF and Blood Pressure Regulation After Prolonged Sitting

NCT07396857Recruiting

Sponsor
Université de Sherbrooke
Start
Nov 2025
Primary completion
Dec 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Trial of fluconazole (2 arms), sponsored by Université de Sherbrooke. Primary endpoints: Popliteal Low-Flow Mediated Constriction, Acute Blood Pressure and 1 more. Started Nov 2025; status: recruiting.

02

Drugs

fluconazole

Beyond the preview

Go deeper on NCT07396857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07396857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call